Systemic rituximab in the treatment of indolent primary cutaneous B-cell lymphomas. (2019) - Muniesa, C.; Domingo, E.; Fornons, R.; Peñate, Y.; Estrach, T.; Ramón, D.; Medina, S.; Flórez, A.; Ortiz, P.; Sánchez, P.; Torres, I.; Acebo, E.; et al.